Recent innovations in urology have enabled clinicians to preserve the kidney and, with it, kidney function for their patients. Memorial Sloan Kettering researchers showed that kidney-sparing operations can have similar oncologic outcomes as the radical procedures performed in the past for certain types of renal masses. Metastatic clear cell renal cancer (ccRCC) Continue Reading